Efficacy and Safety of Minocycline-Containing Bismuth Quadruple Therapies Versus Standard First-Line Bismuth Quadruple Therapies for <i>Helicobacter pylori</i> Eradication: A Systematic Review and Meta-Analysis.

Infect Dis Rep · 2026 · PMC12922069 · PMID 41718070

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a positive trendno p-value reported

This meta-analysis shows a positive trend for the efficacy of MBQT for H. pylori ; the most compelling evidence comes from the per-protocol analysis, which supports its use in patients who adhere to therapy.

also in 11,005 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.

Efficacy and Safety of Minocycline-Containing Bismuth Quadruple Therapies Versus Standard First-Line Bismuth Quadruple Therapies for &lt;i&gt;Helicobacter pylori&lt;/i&gt; Eradication: A Systematic Review and Meta-Analysis.

The sentences

Efficacy and Safety of Minocycline-Containing Bismuth Quadruple Therapies Versus Standard First-Line Bismuth Quadruple Therapies for <i>Helicobacter pylori</i> Eradication: A Systematic Review and Meta-Analysis.